Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets. (Q35917498)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

main subject

cystic fibrosis

0 references

Pseudomonas aeruginosa

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Daniel J Hassett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

611-623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

DNA-looping and enhancer activity: association between DNA-bound NtrC activator and RNA polymerase at the bacterial glnA promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and Pseudomonas infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The CF salt controversy: in vivo observations and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Bacterial genomics. Pump up the versatility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The relationship of degradative and resistance plasmids of Pseudomonas belonging to the same incompatibility group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Apparent antagonism by a resident R plasmid for entry of related gentamicin-tobramycin resistance plasmids in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Mechanisms of antibiotic resistance in bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Bacterial quorum sensing in pathogenic relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Cloning, analysis and expression of an rpoS homologue gene from Pseudomonas aeruginosa PAO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Gene expression in Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The involvement of cell-to-cell signals in the development of a bacterial biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Use of In-Biofilm Expression Technology To Identify Genes Involved in Pseudomonas aeruginosa Biofilm Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

P. aeruginosa quorum-sensing systems and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

The innate immune system in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Plasma membrane water permeability of cultured cells and epithelia measured by light microscopy with spatial filtering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

In vivo airway surface liquid Cl- analysis with solid-state electrodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Nitric oxide in biological denitrification: Fe/Cu metalloenzyme and metal complex NO(x) redox chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

An animal model for cystic fibrosis made by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

Status of gene therapy for cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2.4.611

21 January 2018

Identifiers

DOI

10.1586/14787210.2.4.611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482224%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference